Phase 4UnknownINTERVENTIONAL
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
ClinicalTrials.gov · NCT04575194 · Registry updated: 2020-10-08
- Condition / research focus
- Obesity; Blood Pressure
- Sponsor
- National and Kapodistrian University of Athens
- Countries with listed sites
- Greece
- Registry dates and results
- Start: 2020-09-08. Completion: 2023-05-30 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Liraglutide 6 MG/ML [Saxenda] (drug)
- Naltrexone-Bupropion Combination (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- First Department of Propaedeutic Internal Medicine
Athens, Greece
Site recruitment: Recruiting